"10.1371_journal.pone.0084057","plos one","2013-12-31T00:00:00Z","Alixe H M Kilgour; Iain J Gallagher; Alasdair M J MacLullich; Ruth Andrew; Calum D Gray; Philippa Hyde; Henning Wackerhage; Holger Husi; James A Ross; John M Starr; Karen E Chapman; Kenneth C H Fearon; Brian R Walker; Carolyn A Greig","Centre for Cognitive Ageing and Cognitive Epidemiology, Geriatric Medicine Unit, University of Edinburgh, Edinburgh, United Kingdom; Department of Clinical and Surgical Sciences, Division of Health Sciences, School of Clinical Sciences, University of Edinburgh, Edinburgh, United Kingdom; Endocrinology Unit, Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom; Clinical Research Imaging Centre, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom; School of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom","Conceived and designed the experiments: AMJM HW JR BW KCHF CAG. Performed the experiments: IG PH HW CAG. Analyzed the data: AHMK IG RA CG PH HW JS BW CAG. Contributed reagents/materials/analysis tools: CG HH RA KC BW. Wrote the paper: AHMK JS KCHF BW CAG.","B.R.W. is an inventor on relevant patents owned by the University of Edinburgh and has consulted for several companies developing selective 11βHSD1 inhibitors. No other potential conflicts of interest relevant to this article were reported. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and material.","2013","12","Alixe H M Kilgour","AHMK",14,TRUE,6,4,9,5,TRUE,TRUE,FALSE,0,NA,FALSE
